Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04114058 · ClinicalTrials.gov registry record · Phase 4
A Study Comparing Fascia Iliaca Blockade vs Extracapsular Local Field Infiltration With Liposomal Bupivacaine
A Phase 4 study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 37
- Enrollment target
NCT04114058 is a Phase 4 study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 37 participants.
The verdict
NCT04114058, a Phase 4 study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of fascia iliaca blockade vs local field infiltration with liposomal bupivicaine in controlling pain, narcotic utilization and falls in the postoperative period following hip arthroscopy
Interventions
- DRUG liposomal bupivicaine
- PROCEDURE Fascia iliaca blockade
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2019-10-29 |
| Est. Completion | 2020-03-17 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04114058
The ClinicalTrials.gov registry entry for NCT04114058 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which liposomal bupivicaine is the first listed.
NCT04114058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04114058 about?
NCT04114058 is a clinical study titled "A Study Comparing Fascia Iliaca Blockade vs Extracapsular Local Field Infiltration With Liposomal Bupivacaine". The purpose of this study is to compare the effectiveness of fascia iliaca blockade vs local field infiltration with liposomal bupivicaine in controlling pain, narcotic utilization and falls in the postoperative period following hip arthroscopy
What is the current status of trial NCT04114058?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 37 participants. The study started on 2019-10-29. Estimated completion is 2020-03-17.
What interventions are being tested in trial NCT04114058?
The interventions under investigation include: liposomal bupivicaine (DRUG), Fascia iliaca blockade (PROCEDURE).
Who is sponsoring clinical trial NCT04114058?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.